Q-Line Biotech Discloses IPO Proceeds Utilization and 70% Acquisition of Heidelco Medicore
Q-Line Biotech Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 2:40 am
Q-Line Biotech Discloses IPO Proceeds Utilization and 70% Acquisition of Heidelco Medicore CARE Ratings issued Q-Line Biotech's monitoring report for the half-year ended 30th Sep'26, showing utilization of Rs 122.34 crore out of Rs 214.48 crore gross IPO proceeds, with Rs 92.14 crore parked in fixed deposits. A prior Rs 0.98 crore deviation in debt-prepayment charges was reversed and restored. Separately, the board approved acquiring a 70% stake in Heidelco Medicore Private Limited for Rs 26.64 crore in cash, expanding its critical care instruments and consumables business. Heidelco posted H1FY27 turnover of Rs 57.63 crore and PAT of Rs 3.02 crore.
Original exchange filing (PDF)
More announcements from Q-Line Biotech Ltd
- Q-Line Biotech Limited has informed the Exchange regarding 'Submission of audio recording of Earnings Conference Call-13.11.2026'. 路 15 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Investor Presentation 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding a press release dated November 12, 2026, titled "PRESS RELEASE ON FINANCIAL RESULTS 30 SEPTEMBER 2026.". 路 13 Nov 2026
- Q-Line Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchange'. 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Schedule of meet 路 13 Nov 2026
- Q-Line Biotech Limited has informed the Exchange about Board Meeting to be held on 12-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 12 Nov 2026
- Q-Line Biotech Limited has informed the Exchange regarding 'Clarification-'.that due to an inadvertent clerical error, the time in the subject line of the filing was mentioned as 3:00 P.M. instead of 4:15 P.M.We hereby clarify that the correct time of the Board Meeting is 4:15 P.M., as mentioned in the Board Meeting notice. The incorrect reference to 3:00 P.M. in the subject line may kindly be treated as an inadvertent error.We regret the inconvenience caused and request you to take the above cl 路 06 Nov 2026
